SNBL is SEND ready

The FDA requires data from single and repeated-dose general toxicity and carcinogenicity preclinical studies that begin after December 17, 2016 to be submitted electronically in Standard for Exchange of Nonclinical Data (SEND) format.

SNBL uses our custom data collection system and Pinnacle 21 Enterprise to produce datasets for our preclinical studies. We completed validation of our SEND process earlier this year and we are ready to deliver SEND data packages.


Please email us to discuss how we can partner with you on SEND solutions for your preclinical needs.